NR

Nehalben Rajeshbhai Parmar

Active Director Director DIN 11020762
DIN 11020762 First appointment Mar 2025 Primary industry Agriculture
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Nehalben Rajeshbhai Parmar

Data last updated:

Nehalben Rajeshbhai Parmar is a Director at Selvi Biotech Private Limited (since 2025). The company operates in Agriculture.

DIN 11020762
Primary Designation Director
Industry Agriculture
First Appointment 25 Mar 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Selvi Biotech Private Limited U10801GJ2025PTC160671
Director25 Mar 20252025Active

Board colleagues of Nehalben Rajeshbhai Parmar

NameDINCompanyDesignation
Rajeshbhai Jivabhai Parmar11020761Selvi Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Selvi Biotech Private Limited
Premium access

Shareholding and investment profile for Nehalben Rajeshbhai Parmar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nehalben Rajeshbhai Parmar

Nehalben Rajeshbhai Parmar currently holds 1 directorship: Selvi Biotech Private Limited (Director, since 25 Mar 2025).

Nehalben Rajeshbhai Parmar was first appointed on 25 Mar 2025 as Director at Selvi Biotech Private Limited.

The current boards of Nehalben Rajeshbhai Parmar's companies include Rajeshbhai Jivabhai Parmar (Selvi Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available